Guardat en:
| Autor principal: | |
|---|---|
| Format: | Recurso digital |
| Idioma: | |
| Publicat: |
Zenodo
2026
|
| Matèries: | |
| Accés en línia: | https://doi.org/10.5281/zenodo.18769922 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Taula de continguts:
- Liraglutide appears to offer some reductions in cardiovascular events in non-diabetic patients, though significant uncertainties remain regarding its impact on stroke and cardiovascular mortality.